**About the Editor**

### **Angelo Ferraro**

Dr. Angelo Ferraro was awarded by the University of Calabria (Italy) with a degree in Biological Sciences in 2002. In 2010, he finished his PhD in Molecular Medicine at the University of Naples "Federico II"(Italy). His current position, as a senior research fellow, is at the Department of Electronic and Computer Engineer, National Technical University of Athens (NTUA), Greece.

His main fields of research are cancer molecular biology, biomaterials and biotechnologies connected with the use of nanomaterials. Specifically, in the field of cancer molecular biology, his studies have focused on the mutational analysis of oncogenes, deregulation of the MAPK pathway and epigenetic factors such as histone modifier enzymes in thyroid, breast and colon cancers. In recent years, he has been investigating the use of magnetic and non-magnetic nanoparticles as tools against cancer diseases and for biotechnological applications. At NTUA laboratories, he is investigating new approaches to enhance the effectiveness of hyperthermia (over-hyperthermia); the possibility of using rare-earth fluoride-based nanoparticles and photodynamic therapy (PDT) to specifically kill cancer cells; and developing biosensors based on affinity ligands and interdigitated capacitors. Concerning the biotechnological use of nanomaterials, his studies are focused on magnetic nanoparticles and magnetic photobioreactors to cultivate and harvest microalgae biomass. Furthermore, he is developing a technology named Selective Magnetic Separation based on the use of affinity ligands and magnetic beads to isolate from complex mixture organic molecules an inorganic and ions. He has published 70+ peer-reviewed papers (citations>4000; h-index=30).
